Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Operating Expenses: 2011-2024

Historic Operating Expenses for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $53.9 million.

  • Niagen Bioscience's Operating Expenses rose 20.86% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.4 million, marking a year-over-year increase of 8.05%. This contributed to the annual value of $53.9 million for FY2024, which is 4.47% down from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Operating Expenses is $53.9 million, which was down 4.47% from $56.4 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Operating Expenses ranged from a high of $68.6 million in FY2021 and a low of $53.9 million during FY2024.
  • For the 3-year period, Niagen Bioscience's Operating Expenses averaged around $57.2 million, with its median value being $56.4 million (2023).
  • Per our database at Business Quant, Niagen Bioscience's Operating Expenses rose by 24.37% in 2021 and then declined by 10.41% in 2022.
  • Niagen Bioscience's Operating Expenses (Yearly) stood at $55.1 million in 2020, then increased by 24.37% to $68.6 million in 2021, then fell by 10.41% to $61.4 million in 2022, then fell by 8.21% to $56.4 million in 2023, then declined by 4.47% to $53.9 million in 2024.